Assenagon Asset Management S.A. Fibrogen Inc Transaction History

Assenagon Asset Management S.A.

  • $47.8 Billion
  • Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Fibrogen Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 767,663 shares of FGEN stock, worth $268,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
767,663
Holding current value
$268,682
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$0.33 - $1.26 $253,328 - $967,255
767,663 New
767,663 $307,000
Q1 2024

Apr 24, 2024
SELL
$0.73 - $2.73 $1.31 Million - $4.91 Million
-1,798,009 Reduced 80.74%
428,848 $1.01 Million
Q3 2023

Nov 06, 2023
BUY
$0.79 - $2.83 $583,941 - $2.09 Million
739,166 Added 49.69%
2,226,857 $1.92 Million
Q2 2023

Jul 25, 2023
BUY
$2.49 - $20.59 $356,338 - $2.95 Million
143,108 Added 10.64%
1,487,691 $4.02 Million
Q1 2023

Apr 18, 2023
BUY
$15.95 - $25.18 $21.4 Million - $33.9 Million
1,344,583 New
1,344,583 $25.1 Million
Q3 2022

Oct 27, 2022
SELL
$11.4 - $14.6 $5.24 Million - $6.71 Million
-459,345 Reduced 47.21%
513,556 $6.68 Million
Q2 2022

Jul 27, 2022
BUY
$7.94 - $12.96 $5.94 Million - $9.7 Million
748,230 Added 333.03%
972,901 $10.3 Million
Q1 2022

Apr 25, 2022
BUY
$12.02 - $16.79 $1.9 Million - $2.65 Million
158,058 Added 237.28%
224,671 $2.7 Million
Q4 2021

Feb 01, 2022
BUY
$9.93 - $15.39 $661,467 - $1.03 Million
66,613 New
66,613 $939,000
Q2 2020

Jul 21, 2020
SELL
$32.57 - $42.83 $1.89 Million - $2.49 Million
-58,053 Closed
0 $0
Q1 2020

Apr 17, 2020
SELL
$23.3 - $45.96 $326,433 - $643,899
-14,010 Reduced 19.44%
58,053 $2.02 Million
Q4 2019

Jan 17, 2020
BUY
$34.58 - $48.06 $2.49 Million - $3.46 Million
72,063 New
72,063 $3.09 Million
Q3 2019

Oct 16, 2019
SELL
$36.98 - $48.45 $850,650 - $1.11 Million
-23,003 Closed
0 $0
Q2 2019

Aug 12, 2019
SELL
$35.13 - $55.53 $1.18 Million - $1.87 Million
-33,668 Reduced 59.41%
23,003 $1.04 Million
Q1 2019

Apr 26, 2019
BUY
$42.83 - $59.91 $424,017 - $593,109
9,900 Added 21.17%
56,671 $3.08 Million
Q4 2018

Jan 23, 2019
BUY
$37.97 - $60.16 $1.78 Million - $2.81 Million
46,771 New
46,771 $2.17 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email